As of January 1, all compounding pharmacies are eligible to enroll in The Joint Commission’s new Medication Compounding Certification (MCC) program, including organizations not accredited by The Joint Commission. The accreditor says that the goal of the MCC program is to:
- Ensure pharmacies are compliant with United States Pharmacopeial Convention (USP) and Joint Commission standards
- Reduce the risk and harm stemming from drug compounding
- Uncover and fix problems in existing compounding policies and procedures
- Train personnel on the correct use of PPE and aseptic techniques
- Ensure the physical environment meets guidelines for cleaning and documentation
- Ensure the proper labeling, dating, and sterility of compounded products
In the March edition of The Joint Commission’s Perspectives, the accreditor writes that the program was created in part as a response to national outbreaks from contaminated compounded medicines. The Joint Commission has eligibility requirements and free 90-day access to the MCC standards on its website and in the E-dition® of the Medication Compounding Certification Manual. Their website also will be updated with a list of U.S. states that require compliance with USP General Chapter <795> and USP General Chapter <797>. The MCC standards have also been updated to reflect USP General Chapter <800> Hazardous Drugs—Handling in Healthcare Settings which was reported on previously in the Patient Safety Monitor Journal.
For more information on the certification contact either:
Hospital-based pharmacies: Brian R. Johnson, 630-792-5144 or email@example.com.
Home care pharmacies: Cynthia Cook, 630-792-5121 or firstname.lastname@example.org